Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1691
| Despition | MGLL Human Recombinant |
| SIZE | 2 µg |
| Purity | > 85.0% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1813 | Human HAAO Protein (AC1813) | 5 µg | inquiry |
| ACPP-1827 | Human NHLH2 Protein (AC1827) | 2 µg | inquiry |
| ACPP-1464 | Human ERLIN2 Protein (AC1464) | 5 µg | inquiry |
| ACPP-1332 | GAD65 Blocking Peptide (AC1332) | 250 µg | inquiry |
| ACPP-1076 | Synaptophysin Blocking Peptide (AC1076) | 250 µg | inquiry |
| ACPP-1137 | Recombinant HuD Antigen (AC1137) | 100 µg | inquiry |
| ACPP-1579 | Human Leptin Protein, His (AC1579) | 5 µg | inquiry |
| ACPP-1796 | Human GAP43 Protein (AC1796) | 2 µg | inquiry |
| ACPP-1812 | Human IMPA1 Protein (AC1812) | 5 µg | inquiry |
| ACPP-1246 | Bestrophin Blocking Peptide (AC1246) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.